Halozyme to Host Investor Business Forum and Long-Term Outlook Call

SAN DIEGO, Jan. 12, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that it will host an Investor Business Forum and Long-Term Outlook Call on Wednesday, January 17, 2024 at 5:30 a.m. PT / 8:30 a.m. ET. On the call, Dr. Helen Torley, President…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks